Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 241

1.

Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.

Demeule M, Beaudet N, Régina A, Besserer-Offroy É, Murza A, Tétreault P, Belleville K, Ché C, Larocque A, Thiot C, Béliveau R, Longpré JM, Marsault É, Leduc R, Lachowicz JE, Gonias SL, Castaigne JP, Sarret P.

J Clin Invest. 2014 Mar;124(3):1199-213. doi: 10.1172/JCI70647. Epub 2014 Feb 17.

2.

Olive oil compounds inhibit vascular endothelial growth factor receptor-2 phosphorylation.

Lamy S, Ouanouki A, Béliveau R, Desrosiers RR.

Exp Cell Res. 2014 Mar 10;322(1):89-98. doi: 10.1016/j.yexcr.2013.11.022. Epub 2013 Dec 8.

PMID:
24326154
3.

MT1-MMP expression level status dictates the in vitro action of lupeol on inflammatory biomarkers MMP-9 and COX-2 in medulloblastoma cells.

Annabi B, Vaillancourt-Jean E, Béliveau R.

Inflammopharmacology. 2013 Feb;21(1):91-9. doi: 10.1007/s10787-012-0142-8. Epub 2012 Jun 16.

PMID:
22707305
4.

Resveratrol Targeting of Carcinogen-Induced Brain Endothelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent.

Annabi B, Lord-Dufour S, Vézina A, Béliveau R.

Drug Target Insights. 2012;6:1-11. doi: 10.4137/DTI.S9442. Epub 2012 Apr 11.

5.

Diet-derived polyphenols inhibit angiogenesis by modulating the interleukin-6/STAT3 pathway.

Lamy S, Akla N, Ouanouki A, Lord-Dufour S, Béliveau R.

Exp Cell Res. 2012 Aug 1;318(13):1586-96. doi: 10.1016/j.yexcr.2012.04.004. Epub 2012 Apr 11.

PMID:
22522122
6.

Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration.

Michaud-Levesque J, Bousquet-Gagnon N, Béliveau R.

Exp Cell Res. 2012 May 1;318(8):925-35. doi: 10.1016/j.yexcr.2012.02.017. Epub 2012 Feb 26.

PMID:
22394507
7.

Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1.

Bertrand Y, Currie JC, Poirier J, Demeule M, Abulrob A, Fatehi D, Stanimirovic D, Sartelet H, Castaigne JP, Béliveau R.

Br J Cancer. 2011 Nov 22;105(11):1697-707. doi: 10.1038/bjc.2011.427. Epub 2011 Oct 25.

8.

Colorectal cancer prevention through dietary and lifestyle modifications.

Gingras D, Béliveau R.

Cancer Microenviron. 2011 Aug;4(2):133-9. doi: 10.1007/s12307-010-0060-5. Epub 2011 Jan 13.

9.

Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells.

Annabi B, Vaillancourt-Jean E, Weil AG, Béliveau R.

Onco Targets Ther. 2010 Nov 15;3:219-26. doi: 10.2147/OTT.S14503.

10.

Propranolol suppresses angiogenesis in vitro: inhibition of proliferation, migration, and differentiation of endothelial cells.

Lamy S, Lachambre MP, Lord-Dufour S, Béliveau R.

Vascul Pharmacol. 2010 Nov-Dec;53(5-6):200-8. doi: 10.1016/j.vph.2010.08.002. Epub 2010 Aug 20.

PMID:
20732454
11.

Inhibition of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation blocks tumor progression in mice.

Nyalendo C, Sartelet H, Gingras D, Béliveau R.

Anticancer Res. 2010 Jun;30(6):1887-95.

PMID:
20651331
12.

Members of the low-density lipoprotein receptor-related proteins provide a differential molecular signature between parental and CD133+ DAOY medulloblastoma cells.

Annabi B, Doumit J, Plouffe K, Laflamme C, Lord-Dufour S, Béliveau R.

Mol Carcinog. 2010 Jul;49(7):710-7. doi: 10.1002/mc.20645.

PMID:
20564348
13.

New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration.

Ché C, Yang G, Thiot C, Lacoste MC, Currie JC, Demeule M, Régina A, Béliveau R, Castaigne JP.

J Med Chem. 2010 Apr 8;53(7):2814-24. doi: 10.1021/jm9016637.

PMID:
20210346
14.

Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts.

Perry MC, Demeule M, Régina A, Moumdjian R, Béliveau R.

Mol Nutr Food Res. 2010 Aug;54(8):1192-201. doi: 10.1002/mnfr.200900277.

PMID:
20087857
15.

Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression.

Nyalendo C, Sartelet H, Barrette S, Ohta S, Gingras D, Béliveau R.

BMC Cancer. 2009 Dec 4;9:422. doi: 10.1186/1471-2407-9-422.

16.

Tissue factor mediates the HGF/Met-induced anti-apoptotic pathway in DAOY medulloblastoma cells.

Provençal M, Berger-Thibault N, Labbé D, Veitch R, Boivin D, Rivard GE, Gingras D, Béliveau R.

J Neurooncol. 2010 May;97(3):365-72. doi: 10.1007/s11060-009-0041-z. Epub 2009 Nov 18.

PMID:
19921488
17.

Transport characteristics of a novel peptide platform for CNS therapeutics.

Bertrand Y, Currie JC, Demeule M, Régina A, Ché C, Abulrob A, Fatehi D, Sartelet H, Gabathuler R, Castaigne JP, Stanimirovic D, Béliveau R.

J Cell Mol Med. 2010 Dec;14(12):2827-39. doi: 10.1111/j.1582-4934.2009.00930.x.

18.

P-glycoprotein deficient mouse in situ blood-brain barrier permeability and its prediction using an in combo PAMPA model.

Dagenais C, Avdeef A, Tsinman O, Dudley A, Beliveau R.

Eur J Pharm Sci. 2009 Sep 10;38(2):121-37. doi: 10.1016/j.ejps.2009.06.009. Epub 2009 Jul 8.

19.

Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion.

Annabi B, Lachambre MP, Plouffe K, Moumdjian R, Béliveau R.

Pharmacol Res. 2009 Nov;60(5):438-45. doi: 10.1016/j.phrs.2009.05.005. Epub 2009 May 23.

PMID:
19467330
20.

Emerging concepts in the regulation of membrane-type 1 matrix metalloproteinase activity.

Gingras D, Béliveau R.

Biochim Biophys Acta. 2010 Jan;1803(1):142-50. doi: 10.1016/j.bbamcr.2009.04.011. Epub 2009 May 4. Review.

Supplemental Content

Loading ...
Support Center